W
Wolfgang Becker
Researcher at University of Bamberg
Publications - 261
Citations - 3394
Wolfgang Becker is an academic researcher from University of Bamberg. The author has contributed to research in topics: Immunoscintigraphy & Antibody. The author has an hindex of 31, co-authored 257 publications receiving 3187 citations. Previous affiliations of Wolfgang Becker include University of Erlangen-Nuremberg.
Papers
More filters
Journal Article
Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives.
Thomas M. Behr,Robert M. Sharkey,Malik E. Juweid,Rosalyn D. Blumenthal,Robert M. Dunn,Gary L. Griffiths,Hans-J. Bair,F. Wolf,Wolfgang Becker,David M. Goldenberg +9 more
TL;DR: A variety of basic compounds is capable of inhibiting the tubular reabsorption of peptides and proteins, thus lowering the kidney uptake of antibody fragments significantly, and their role as imaging and therapeutic agents may be expanded.
Journal ArticleDOI
The use of monoclonal antibodies and antibody fragments in the imaging of infectious lesions
TL;DR: Antigranulocyte Fab'-fragment may have its advantage in an earlier localization of infectious lesions (1 hour) owing to its smaller molecular size and its lower affinity for its epitope, which may be promising in the detection of spinal infections and in infections in regions with the presence of normal bone marrow.
Journal Article
Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors.
Thomas M. Behr,Niels Jenner,Martin Béhé,Christa Angerstein,Stefan Gratz,Friedhelm Raue,Wolfgang Becker +6 more
TL;DR: CCK/gastrin analogs may be a useful new class of receptor-binding peptides for diagnosis and therapy of CCK-B receptor-expressing tumors, such as MTC or small cell lung cancer.
Journal Article
High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model
Thomas M. Behr,Martin Béhé,Michael G. Stabin,Eike Wehrmann,Christos Apostolidis,R. Molinet,Frank Strutz,Afshin Fayyazi,Eberhard Wieland,Stefan Gratz,Lothar Koch,David M. Goldenberg,Wolfgang Becker +12 more
TL;DR: Assessment of the toxicity and antitumor efficacy of RIT with the alpha emitter 213Bi/213Po, as compared to the beta emitter 90Y, linked to a monovalent Fab' fragment in a human colonic cancer xenograft model in nude mice shows that R IT with alpha emitters may be therapeutically more effective than conventional beta emitters.
Journal Article
Detection of soft-tissue infections and osteomyelitis using a technetium-99m-labeled anti-granulocyte monoclonal antibody fragment
Wolfgang Becker,Jürgen Bair,Thomas M. Behr,Roland Repp,Holger Streckenbach,Heinrich Beck,Martin Gramatzki,M.J. Winship,David M. Goldenberg,F. Wolf +9 more
TL;DR: Investigation of the use of 99mTc-murine anti-granulocyte monoclonal Fab' fragment in patients with suspected osteomyelitis of soft-tissue infections found it offers rapid localization of foci, rapid and simple use, a negligible HAMA response rate, no effect on granulocyte function and an accuracy comparable to WBC scanning.